Cited by 305Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism

Open access
Song, Wilbur M., Joshita, Satoru, Zhou, Yingyue, Ulland, Tyler K., Gilfillan, Susan, Colonna, Marco·2018·Journal of Experimental Medicine

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disease that causes late-onset dementia. The R47H variant of the microglial receptor TREM2 triples AD risk in genome-wide association studies. In mouse AD models, TREM2-deficient microglia fail to proliferate and cluster around the amyloid-β plaques characteristic of AD. In vitro, the common variant (CV) of TREM2 binds anionic lipids, whereas R47H mutation impairs binding. However, in vivo, the identity of TREM2 ligands and effect of the R47H variant remain unknown. We generated transgenic mice expressing human CV or R47H TREM2 and lacking endogenous TREM2 in the 5XFAD AD model. Only the CV transgene restored amyloid-β–induced microgliosis and microglial activation, indicating that R47H impairs TREM2 function in vivo. Remarkably, soluble TREM2 was found on neurons and plaques in CV- but not R47H-expressing 5XFAD brains, although in vitro CV and R47H were shed similarly via Adam17 proteolytic activity. These results demonstrate that TREM2 interacts with neurons and plaques duing amyloid-β accumulation and R47H impairs this interaction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20171529

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mice carrying R47H variation display impaired binding of TREM2 with anionic and zwitterionic lipids known to associate with fibrillar Aβ, leading to failure of microglia to cluster around Aβ plaques, apoptosis, augmented Aβ accumulation, and spread of neuritic plaque tau aggregates.

    “Mice carrying R47H variation displayed impaired binding of TREM2 with anionic and zwitterionic lipids which are known to associate with fibrillar Aβ. As a result, microglia failed to cluster around Aβ plaques and became apoptotic, subsequently leading to augmented Aβ accumulation,198,199 and spread of neuritic plaque tau aggregates.200”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [199]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Loss of TREM2 function in Alzheimer's disease mouse models limits microglial plaque surrounding, proliferation, and conversion to disease-associated microglia, leading to more severe neuritic dystrophy.

    “loss of TREM2 function in AD mouse models restricts the ability of microglia to surround Aβ plaques15,16, proliferate, and convert to DAM10,15,17, which in turn leads to more profound neuritic dystrophy18,19.”
  • In mouse models of Alzheimer's disease, the disease-associated microglia program depends on TREM2.

    “activation of “disease-associated microglia” (DAM) is dependent on TREM2 in mouse models of AD.”
  • sTREM2 directly binds to neurons in mouse models of AD and inhibits LTP induction.

    “experimental evidence revealed that sTREM2 directly bound to neurons in mouse models of AD194 and inhibited LTP induction.”
  • Aβ-induced microglial activation is impaired in humanized transgenic mice expressing human R47H TREM2, and the R47H mutation impairs TREM2 binding to anionic lipids.

    “Aβ-induced microglial activation is impaired in humanized transgenic mice expressing human R47H TREM2 (REF.169), and the R47H mutation impairs TREM2 binding to anionic lipids166.”

    From Microglial signatures and their role in health and disease (2018) · cites this paper as [169]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 50 · Cited by 305

Research works printed but not linked: 1

  1. Korvatska O., Leverenz J.B., Jayadev S., McMillan P., Kurtz I., Guo X., Rumbaugh M., Matsushita M., Girirajan S., Dorschner M.O., 2015 R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. JAMA Neurol. 72: 920– 927. 10.1001/jamaneurol.2015.0979 26076170 PMC4825672 · DOI · Paper page

Authors
Song, W. M., Joshita, S., Zhou, Y., Ulland, T. K., Gilfillan, S., & Colonna, M.
Affiliations
  • Washington University in St. Louis (US)
  • Shinshu University (JP)
Corresponding author
Colonna, Marco
Venue
Journal of Experimental Medicine
Published
2018-01-10
Volume
215
Issue
3
Pages
745-760
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2784206224
Cited by
305
References
50
Citations by year
2026: 27 · 2025: 35 · 2024: 31 · 2023: 58 · 2022: 23 · 2021: 38 · 2020: 26 · 2019: 33 · 2018: 33
FWCI
14.51
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders
  • National Cancer Institute (P30 CA91842)
  • Institute of Clinical and Translational Sciences
  • Clinical and Translational Science Awards
  • National Center for Research Resources (UL1TR000448)
  • National Institutes of Health
  • Washington University School of Medicine in St. Louis
  • Children’s Discovery Institute of Washington University
  • St. Louis Children’s Hospital (CDI-CORE-2015-505)
  • National Institute for Neurological Disorders and Stroke (NS086741)
  • NIH (5T32CA009547-30, P30DK052574, P30DK020579, RF1 AG05148501)
  • Cure Alzheimer’s Fund
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
TREM2, Alzheimer's disease, microglia, amyloid plaques, microglial activation, soluble TREM2, microglia-neuron interaction, 5xFAD mice
MeSH terms
ADAM17 Protein, Animals, Brain, Cell Count, Gliosis, Humans, Membrane Glycoproteins, Mice, Transgenic, Neurons, Receptors, Immunologic, Solubility, Microglia, Polymorphism, Single Nucleotide, Myeloid Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review